Dianzumba S B, DiPette D, Joyner C R, Townsend R, Weber E, Mauro K, Cornman C
Department of Medicine, Allegheny General Hospital, Allegheny-Singer Research Institute, Pittsburgh, PA 15212.
Hypertension. 1988 Feb;11(2 Pt 2):I98-102. doi: 10.1161/01.hyp.11.2_pt_2.i98.
We previously used the Doppler transmitral flow velocity ratio A/E (A = late ventricular filling peak velocity; E = early ventricular filling peak velocity) and the age-adjusted ratio A/E/Age to detect left ventricular filling abnormalities in untreated mild hypertension. This study is a double-blind assessment of the effect of combined alpha- and beta-blockade (labetalol) and beta-blockade alone (atenolol) on left ventricular filling in mild hypertension. Twenty-seven patients blindly randomized to labetalol (12 patients) and atenolol (15 patients) treatment completed the echocardiographic and Doppler studies. Clinical and echo-Doppler data obtained at baseline and 6 weeks after initiation of therapy showed no difference between the two groups for age (49 +/- 10 vs 46 +/- 10 years), mean blood pressure (before therapy, 118 +/- 9 vs 117 +/- 8 mm Hg; after therapy, 108 +/- 12 mm Hg), left ventricular dimensions, wall thickness, systolic function, and mean late filling velocity A. There was no significant change in left ventricular mass and mass index with labetalol (left ventricular mass, 211 +/- 36 vs 216 +/- 38; mass index, 110 +/- 17 vs 112 +/- 16) or atenolol (245 +/- 41 vs 271 +/- 65; 120 +/- 18 vs 130 +/- 35). The mean velocity E, A/E, and A/E/Age ratios significantly improved with labetalol (p less than 0.05) but did not change significantly with atenolol. The improvement in A/E and A/E/Age ratios was primarily due to an increase in early filling velocity E.(ABSTRACT TRUNCATED AT 250 WORDS)
我们之前使用多普勒二尖瓣血流速度比值A/E(A = 心室晚期充盈峰值速度;E = 心室早期充盈峰值速度)以及年龄校正比值A/E/Age来检测未经治疗的轻度高血压患者的左心室充盈异常情况。本研究是一项双盲评估,旨在探究联合使用α和β受体阻滞剂(拉贝洛尔)以及单独使用β受体阻滞剂(阿替洛尔)对轻度高血压患者左心室充盈的影响。27例患者被随机分为两组,分别接受拉贝洛尔治疗(12例)和阿替洛尔治疗(15例),并完成了超声心动图和多普勒研究。在基线期及治疗开始6周后获得的临床和超声多普勒数据显示,两组患者在年龄(49±10岁 vs 46±10岁)、平均血压(治疗前,118±9 mmHg vs 117±8 mmHg;治疗后,108±12 mmHg)、左心室尺寸、室壁厚度、收缩功能以及平均晚期充盈速度A方面均无差异。使用拉贝洛尔(左心室质量,211±36 vs 216±38;质量指数,110±17 vs 112±16)或阿替洛尔(245±41 vs 271±65;120±18 vs 130±35)治疗后,左心室质量和质量指数均无显著变化。拉贝洛尔治疗后平均速度E、A/E以及A/E/Age比值显著改善(p<0.05),而阿替洛尔治疗后则无显著变化。A/E和A/E/Age比值的改善主要归因于早期充盈速度E的增加。(摘要截断于250字)